Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?

被引：0

|

作者：

María-Isabel Farfan-Portet

Sophie Gerkens

Isabelle Lepage-Nefkens

Irmgard Vinck

Frank Hulstaert

机构：

[1] Belgian Health Care Knowledge Centre,

来源：

The European Journal of Health Economics | 2014年 / 15卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：223 / 228

页数：5

相关论文

共 50 条

[21] EXPENDITURE LIMITS AND COST-CONTAINMENT
GINSBURG, PB
INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING, 1993, 30 (04) : 389 - 399
[22] COST-CONTAINMENT IN UROLOGY - COMMENT
MONTIE, JE
UROLOGY, 1995, 46 (01) : 25 - 25
[23] COST-CONTAINMENT INCENTIVES HEALTHY
SHAW, MA
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1984, 41 (04): : 654 - 654
[24] COST-CONTAINMENT IN UROLOGY - REPLY
KOCH, MO
SMITH, JA
UROLOGY, 1995, 46 (01) : 25 - 26
[25] Cost-containment as part of pharmaceutical policy (vol 27, pg 144, 2005)
Almarsdóttir, AB
Traulsen, JM
PHARMACY WORLD & SCIENCE, 2005, 27 (04): : 355 - 355
[26] COST-CONTAINMENT IN CRITICAL CARE
BIRNBAUM, ML
CRITICAL CARE MEDICINE, 1986, 14 (12) : 1068 - 1077
[27] Good cost-containment for Assmang
Mining Mirror, 1999, 11 (09):
[28] COST-CONTAINMENT OF ANTIMICROBIAL THERAPY
BARRIERE, SL
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1985, 19 (04): : 278 - 281
[29] COST-CONTAINMENT AND STRAINS OF COMMITMENT
DANIELS, N
HASTINGS CENTER REPORT, 1989, 19 (05) : 47 - 47
[30] CARDIOLOGY BY THE NUMBERS AND COST-CONTAINMENT
KNOEBEL, SB
AMERICAN JOURNAL OF CARDIOLOGY, 1988, 61 (13): : 1112 - 1115

← 1 2 3 4 5 →